Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Guangdong Xiangshan Tang Pharmaceutical is a modern high-tech pharmaceutical group headquartered in Zhongshan, Guangdong Province, China. Founded in 1958 and originating from the Xiaolan Pharmaceutical Factory, the company has over 60 years of history in pharmaceutical research, development, manufacturing, and trade. Xiangshan Tang operates multiple GMP-certified production lines across its Xiaolan, Nanlang, and Yongning campuses, covering oral liquids, tablets, capsules, granules, and ointments. The company holds 87 drug approvals, featuring a diverse portfolio of traditional Chinese medicines and chemical generics, including exclusive products like Huangdi Yangxue Oral Liquid and Qingmei Ganmao Granules. Dedicated to preserving Lingnan medicine culture, the group focuses on therapeutic areas such as respiratory health, dermatology, gastroenterology, and cardiovascular diseases.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Guangdong Xiangshan Tang Pharmaceutical.